AIFortune3 days ago
AI drug discovery leaders warn U.S. funding cuts risk lag
3 min read
AI drug discovery leaders warned at Fortune Brainstorm Tech that U.S. health funding cuts risk falling behind global rivals. Lila Sciences CEO Geoffrey von Maltzahn called falling below an adversary's scientific intelligence an unimaginable competitive disadvantage. NVIDIA healthcare VP Kimberly Powell said defunding now while Europe and Asia lean in will leave the U.S. behind.
Level
Hype check
Tap to vote and see what everyone thinks.
